Additional factory approved to supply AstraZeneca vaccine to M'sia

2 Apr 2021, 10:09 am

Updated 3 months ago


Malaysia’s Drug Control Authority (DCA) has granted conditional approval for a second source of the Covid-19 vaccine co-developed by AstraZeneca and the University of Oxford, bringing the vaccine a step closer towards its use in the country’s ongoing vaccination campaign.

In a statement today, Health Ministry director-general Dr Noor Hisham Abdullah said the DCA agreed to register AstraZeneca’s contract manufacturer SK Bioscience Co Ltd in South Korea, during a meeting today...

All Access Plan


per month
Unlimited access to our articles
Comment on all our stories
Gift articles to your friends
Subscribe Now
You can cancel anytime.
Secure and Encrypted
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In

View Comments (0)